Skip to main content

Market Overview

Benzinga's Top Upgrades, Downgrades For June 29, 2020

Share:

Upgrades

  • SunTrust Robinson Humphrey changed the rating for CoreLogic Inc (NYSE: CLGX) from Hold to Buy. In the first quarter, CoreLogic showed an EPS of $0.76, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $68.40 and a 52-week-low of $24.69. CoreLogic's stock last closed at $67.95 per share.
  • For Big Lots Inc (NYSE: BIG), Loop Capital upgraded the stock from Hold to Buy. For the first quarter, Big Lots had an EPS of $1.26, compared to year-ago quarter EPS of $0.92. The stock has a 52-week-high of $44.90 and a 52-week-low of $10.12. Big Lots's stock last closed at $43.02 per share.
  • For Southwest Airlines Co (NYSE: LUV), Goldman Sachs upgraded the stock from Sell to Buy. For the first quarter, Southwest Airlines had an EPS of ($0.15), compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of $58.83 and a 52-week-low of $22.46. Southwest Airlines's stock last closed at $31.96 per share.
  • Raymond James upgraded the stock for CDW Corp (NASDAQ: CDW) from Market Perform to Outperform. In the first quarter, CDW showed an EPS of $1.38, compared to $1.24 from the year-ago quarter. The stock has a 52-week-high of $146.09 and a 52-week-low of $73.39. CDW's stock last closed at $108.49 per share.
  • Evercore ISI Group changed the rating for Chart Industries Inc (NASDAQ: GTLS) from In-Line to Outperform. In the first quarter, Chart Industries showed an EPS of $0.57, compared to $0.39 from the year-ago quarter. The stock has a 52-week-high of $78.80 and a 52-week-low of $15.00. Chart Industries's stock last closed at $45.22 per share.
  • For The Middleby Corp (NASDAQ: MIDD), KeyBanc upgraded the stock from Sector Weight to Overweight. The Middleby earned $1.33 in the first quarter, compared to $1.38 in the year-ago quarter. The stock has a 52-week-high of $142.98 and a 52-week-low of $41.73. The Middleby's stock last closed at $72.98 per share.

 

Downgrades

  • Credit Suisse changed the rating for AMC Entertainment Holdings Inc (NYSE: AMC) from Neutral to Underperform. For the first quarter, AMC Entertainment had an EPS of ($2.22), compared to year-ago quarter EPS of ($1.25). The stock has a 52-week-high of $12.49 and a 52-week-low of $1.95. AMC Entertainment's stock last closed at $4.16 per share.
  • For Beyond Meat Inc (NASDAQ: BYND), Barclays downgraded the stock from Overweight to Underweight. Beyond Meat earned $0.03 in the first quarter, compared to ($0.14) in the year-ago quarter. The stock has a 52-week-high of $239.71 and a 52-week-low of $48.18. Beyond Meat's stock last closed at $141.68 per share.
  • For Cinemark Holdings Inc (NYSE: CNK), Credit Suisse downgraded the stock from Outperform to Neutral. For the first quarter, Cinemark Hldgs had an EPS of ($0.37), compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $41.60 and a 52-week-low of $5.71. Cinemark Hldgs's stock last closed at $11.39 per share.
  • Wells Fargo downgraded the stock for CoreLogic Inc (NYSE: CLGX) from Overweight to Equal-Weight. CoreLogic earned $0.76 in the first quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $68.40 and a 52-week-low of $24.69. CoreLogic's stock last closed at $67.95 per share.
  • For Diamondback Energy Inc (NASDAQ: FANG), BMO Capital downgraded the stock from Outperform to Market Perform. In the first quarter, Diamondback Energy showed an EPS of $1.45, compared to $1.39 from the year-ago quarter. The stock has a 52-week-high of $111.84 and a 52-week-low of $14.55. Diamondback Energy's stock last closed at $41.13 per share.
  • For Fiserv Inc (NASDAQ: FISV), Oppenheimer downgraded the stock from Outperform to Perform. Fiserv earned $0.99 in the first quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $125.05 and a 52-week-low of $73.50. Fiserv's stock last closed at $94.92 per share.
  • Goldman Sachs changed the rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) from Buy to Neutral. For the first quarter, Neurocrine Biosciences had an EPS of $0.82, compared to year-ago quarter EPS of ($1.12). The stock has a 52-week-high of $131.00 and a 52-week-low of $72.14. Neurocrine Biosciences's stock last closed at $130.36 per share.
  • BMO Capital changed the rating for Pilgrims Pride Corp (NASDAQ: PPC) from Outperform to Market Perform. In the first quarter, Pilgrims Pride showed an EPS of $0.18, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $33.67 and a 52-week-low of $15.75. Pilgrims Pride's stock last closed at $16.69 per share.
  • Guggenheim downgraded the stock for Spotify Technology SA (NYSE: SPOT) from Neutral to Sell. In the first quarter, Spotify Technology showed an EPS of ($0.22), compared to ($0.90) from the year-ago quarter. The stock has a 52-week-high of $271.71 and a 52-week-low of $109.18. Spotify Technology's stock last closed at $265.05 per share.
  • HC Wainwright & Co. downgraded the stock for Inovio Pharmaceuticals Inc (NASDAQ: INO) from Buy to Neutral. For the first quarter, Inovio Pharmaceuticals had an EPS of ($0.26), compared to year-ago quarter EPS of ($0.30). The stock has a 52-week-high of $33.79 and a 52-week-low of $1.92. Inovio Pharmaceuticals's stock last closed at $29.98 per share.

 

Initiations

  • Piper Sandler initiated coverage on Leap Therapeutics Inc (NASDAQ: LPTX) with an Overweight rating. The price target for Leap Therapeutics is set at $6.00. For the first quarter, Leap Therapeutics had an EPS of ($0.55), compared to year-ago quarter EPS of ($0.47). The stock has a 52-week-high of $3.18 and a 52-week-low of $0.57. Leap Therapeutics's stock last closed at $2.19 per share.
  • Jefferies initiated coverage on Madison Square Garden Entertainment Corp (NYSE: MSGE) with a Buy rating. The price target for Madison Square Garden is set at $100.00. The stock has a 52-week-high of $87.20 and a 52-week-low of $62.50. Madison Square Garden's stock last closed at $72.65 per share.
  • HSBC initiated coverage on Otis Worldwide Corp (NYSE: OTIS) with a Reduce rating. The price target for Otis Worldwide is set at $44.00. The stock has a 52-week-high of $61.46 and a 52-week-low of $41.26. Otis Worldwide's stock last closed at $55.82 per share.
  • Cowen & Co. initiated coverage on Pliant Therapeutics Inc (NASDAQ: PLRX) with an Outperform rating. The stock has a 52-week-high of $31.99 and a 52-week-low of $21.05. Pliant Therapeutics's stock last closed at $31.72 per share.
  • JP Morgan initiated coverage on Warner Music Group Corp (NASDAQ: WMG) with an Overweight rating. The price target for Warner Music Group is set at $40.00. The stock has a 52-week-high of $34.76 and a 52-week-low of $26.99. Warner Music Group's stock last closed at $30.47 per share.
  • With a rating of Sector Perform, RBC Capital initiated coverage on ZoomInfo Technologies Inc (NASDAQ: ZI). The price target is set at $50.00 for ZoomInfo Technologies. The stock has a 52-week-high of $64.40 and a 52-week-low of $32.10. ZoomInfo Technologies's stock last closed at $51.57 per share.
  • B of A Securities initiated coverage on ZoomInfo Technologies Inc (NASDAQ: ZI) with a Buy rating. The price target for ZoomInfo Technologies is set at $60.00. The stock has a 52-week-high of $64.40 and a 52-week-low of $32.10. ZoomInfo Technologies's stock last closed at $51.57 per share.
  • Evercore ISI Group initiated coverage on Warner Music Group Corp (NASDAQ: WMG) with an Outperform rating. The price target for Warner Music Group is set at $36.00. The stock has a 52-week-high of $34.76 and a 52-week-low of $26.99. Warner Music Group's stock last closed at $30.47 per share.
  • SVB Leerink initiated coverage on Nuance Communications Inc (NASDAQ: NUAN) with an Outperform rating. The price target for Nuance Communications is set at $31.00. For the second quarter, Nuance Communications had an EPS of $0.21, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $26.01 and a 52-week-low of $13.51. Nuance Communications's stock last closed at $25.39 per share.
  • HC Wainwright & Co. initiated coverage on Arena Pharmaceuticals Inc (NASDAQ: ARNA) with a Buy rating. The price target for Arena Pharmaceuticals is set at $90.00. In the first quarter, Arena Pharmaceuticals showed an EPS of ($2.00), compared to $12.34 from the year-ago quarter. The stock has a 52-week-high of $69.75 and a 52-week-low of $32.95. Arena Pharmaceuticals's stock last closed at $65.92 per share.
  • Needham initiated coverage on Enphase Energy Inc (NASDAQ: ENPH) with a Buy rating. The price target for Enphase Energy is set at $53.00. In the first quarter, Enphase Energy showed an EPS of $0.38, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $70.36 and a 52-week-low of $16.32. Enphase Energy's stock last closed at $45.30 per share.
 

Related Articles (ARNA + AMC)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
ZIWolfe ResearchMaintains75.0
ESPRNeedhamMaintains114.0
TBIOSVB LeerinkMaintains38.0
ATHMCitigroupDowngrades52.0
NEWTRaymond JamesDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com